Titan Pharmaceuticals
TTNP
#11013
Rank
A$8.77 M
Marketcap
A$6.60
Share price
-3.76%
Change (1 day)
7.59%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$6.74 Million, an increase over its 2023 earnings that were of -A$7.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-35.81%
2024 -A$6.74 Million-15.5%
2023 -A$7.97 Million-45.43%
2022 -A$14.61 Million16.29%
2021 -A$12.56 Million-907.36%
2020 A$1.55 M-106.6%
2019 -A$23.56 Million82.4%
2018 -A$12.92 Million-36.93%
2017 -A$20.48 Million-378.62%
2016 A$7.34 M-145.53%
2015 -A$16.15 Million369.37%
2014 -A$3.44 Million-125.9%
2013 A$13.27 M-177.74%
2012 -A$17.08 Million13.59%
2011 -A$15.04 Million74.37%
2010 -A$8.63 Million3.61%
2009 -A$8.33 Million
2007 -A$26.38 Million12.08%
2006 -A$23.54 Million-28.65%
2005 -A$32.99 Million-10.03%
2004 -A$36.67 Million-6.08%
2003 -A$39.04 Million-14.76%
2002 -A$45.8 Million32.52%
2001 -A$34.57 Million27.55%
2000 -A$27.1 Million62.5%
1999 -A$16.68 Million4.04%
1998 -A$16.03 Million49.33%
1997 -A$10.74 Million-27.88%
1996 -A$14.89 Million13.04%
1995 -A$13.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.50 B-934,431.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.21 B-553,468.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-A$0.27 Billion 6,519.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$0.10 B-2,748.84%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$15.39 Million 283.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.47 Billion 11,515.97%๐Ÿ‡บ๐Ÿ‡ธ USA